Fodor's Travel: We will be able to travel this fall?
UC expert sees a fall COVID-19 rebound that is manageable
The general consensus among medical experts is for a rebound of COVID-19 cases in the fall of 2020. Fodor's Travel interviewed Carl Fichtenbaum, MD, of the UC Division of Infectious Diseases for an article on what travel might look like this fall.
Carl Fichtenbaum, MD, of the UC Division of Infectious Diseases, talked to Fodor's Travel about what travel might look like this fall. Photo/Joe Fuqua II/UC Creative + Brand
Even though he believes we’ll still be battling the novel coronavirus in the fall, Dr. Fichtenbaum is hopeful that numbers will be at the level we’re seeing right now and won’t be any higher.
“I think that’s realistic because I think we’ll be able to control a little bit of the spread of this so that it doesn’t get out of control,” he said.
Traveling brings with it the risk of both the traveler and the people they encounter being exposed to the virus. For this reason, Dr. Fichtenbaum cautions anyone thinking about holiday travel (or fall travel in general) to be cognizant of exposures to other people and places in the time leading up to travel. He also suggests limiting exposure by opting to travel by car, if possible.
Read the entire article here.
Lead photo/Fran Boloni/Unsplash
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
The Last Show with David Cooper discusses AI in education with UC’s Joshua Lambert
April 12, 2026
The Last Show with David Cooper, a global news podcast, featured Joshua Lambert, PhD, a professor and biostatistician in UC College of Nursing to discuss his latest research on using artificial intelligence for student advising.
UC enrolls first patients in clinical trial for prosthetic joint infections
April 10, 2026
The University of Cincinnati has enrolled the first patients in Peptilogics’ RETAIN clinical trial, testing an investigational drug for prosthetic joint infections after total knee replacement to reduce repeat surgeries and infection recurrence.
Long before machine guns, ancient Romans used this rapid-fire weapon
April 9, 2026
Smithsonian highlights research by UC Classics Professor Steven Ellis, who supervised archaeological work in the Porta Stabia neighborhood of Pompeii.